#pharmacann

Healthcare & Pharmaceuticals U.S. cannabis firm PharmaCann plans IPO as New York weed legalization lifts demand -sources

Aug 16 (Reuters) – PharmaCann, one of the 10 original cannabis licensees in New York, has confidentially filed for an initial public offering that could value it at well over $1 billion, sources familiar with the matter told Reuters. The planned IPO would help PharmaCann raise funds before New York state begins recreational weed sales, expected sometime next year. The IPO could take place this…

Here’s how millennials and boomers differ on marijuana use

Baby boomers and millennials can’t agree on anything: the economy, social values, and smoking cannabis. Not whether or not they should consume the plant — boomers now smoke more cannabis than high schoolers — but how, when and where and everything in between.

These differences in opinions were seen in a recent survey by Verilife dispensaries, which is part of the Pharmacann network. The…

One of the biggest deals in the cannabis industry just fell apart. What the MedMen-PharmaCann breakup means for marijuana in Illinois.

When MedMen Enterprises agreed to buy Chicago-based PharmaCann last year, the $682 million deal was one of the biggest in the history of the legal marijuana industry. Now, it’s one of the biggest to fall apart.

On Tuesday, the companies announced they were abandoning a transaction that already had been delayed by regulatory hurdles, but MedMen is not walking away empty-handed.

It’s…

MedMen Plunges After Scrapping PharmaCann Merger; Marijuana Stocks Slide

California-based marijuana retailer MedMen (OTC:MMNFF) on Tuesday said it would terminate its merger with PharmaCann and appointed a new CFO, killing off a deal that would have made it one of the biggest cannabis companies in the U.S. MedMen stock plummeted, while Canadian marijuana stocks reclaimed gains.

The announcement came a little less than a month after MedMen said the deal cleared a…